483 Biocon Mar 2018

483 Biocon Mar 2018

Jennifer Adams FDA, Susanne Richardson FDA$119.00 - Available Now

FDA investigators audited the Biocon - Bengaluru, India facility and issued inspectional observations (via FDA 483) on 16 Mar 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 16 Mar 2018
  • Location: Bengaluru, India
  • FEI: 1000172912
Add To Cart